ArticleJAAD case reports2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified with mammalian target of rapamycin mutation: A novel finding for targeted treatment.
Carlo De la Sancha, Callie Burgin, Simon Warren, Kristin Hoffmann, Utpal Davé, Mehdi Nassiri
Abstract readCase Reports
In one paragraphArticle in JAAD case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Carlo De la SanchaDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Callie BurginDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana.
Simon WarrenDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Kristin HoffmannDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana.
Utpal DavéDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana.
Mehdi NassiriDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Funding
The Role of LMO2 in the Pathogenesis of T-cell LeukemiaR01CA207530 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI DAVE, UTPAL P · 2016 to 2020
$1.8MBLRD VA I01 BX001799NCI NIH HHS R01 CA207530
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
BCL6 corepressorBCL6 corepressor lossCD20CD30– cutaneous T-cell lymphomaCD30– lymphomaCD30– T-cell lymphomacutaneous T-cell lymphoma, cutaneous T-cell lymphoma, not otherwise specifiedmammalian target of rapamycinmammalian target of rapamycin inhibitormammalian target of rapamycin mutationmTOR, mammalian target of rapamycinpcPTCL-NOS, primary cutaneous peripheral T-cell lymphoma, not otherwise specifiedperipheral T-cell lymphomaperipheral T-cell lymphoma, not otherwise specifiedperipheral T-cell lymphoma, unspecifiedprimary cutaneous lymphomaprimary cutaneous peripheral T-cell lymphomaprimary cutaneous peripheral T cell lymphoma, not otherwise specifiedrituximabTAK-228T-cell lymphoma
Identifiers
PMID33304974
PMCPMC7711182
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390